Don't Think of Corlanor as a Replacement for Beta-Blockers for Heart Failure
Corlanor (CORE-lah-nore, ivabradine) will be the first new drug approved for systolic heart failure in a decade.
It works by inhibiting the If or "funny" current in the heart. This lowers heart rate...withOUT causing a drop in blood pressure.
Ivabradine prevents 1 in 25 patients from being hospitalized over 2 years...when ADDED to an ACEI or ARB, beta-blocker, and aldosterone antagonist. But it DOESN'T reduce overall mortality.